Implantable medical device sensing wireless ECG as substitute for intracardiac electrogram

• US 8,239,020 B2
• Filed: 03/29/2007
• Issued: 08/07/2012
• Est. Priority Date: 10/28/2004
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Zhang, Yi, McCabe, Aaron, Yonce, David J., Thompson, Julie
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): Bays, Pamela M
• Application Number:
  US11/693,110
• Publication Number:
  US 20070167849A1
• Time in Patent Office: 1,958 Days
• Field of Search: 600/509, 600/515, 600/518, 600/508, 600/517, 607/5, 607/14, 607/18, 607/4, 607/9, 607/17
• US Class Current: 607/9
• CPC Class Codes: A61B 5/287 Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 5/353 Detecting P-waves
• CPC Class Codes: A61B 5/686 Permanently implanted devices, e.g. pacemakers, other stimulators, biochips A61B5/6861 takes precedence
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3706 Pacemaker parameters stimulation threshold A61N1/371
• CPC Class Codes: A61N 1/3712 Auto-capture, i.e. automatic adjustment of the stimulation threshold
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

A cardiac rhythm management (CRM) system includes an implantable medical device that senses a wireless electrocardiogram (ECG), which is a signal sensed with implantable electrodes and approximating a surface ECG. In one embodiment, the wireless ECG is sensed as a substitute signal for the intracardiac electrogram when the sensing of the intracardiac electrogram becomes unreliable.

Claims

1. A cardiac rhythm management (CRM) system, comprising:

a plurality of implantable subcutaneous electrodes; and

an implantable medical device including;

a primary sensing circuit including an electrogram sensing circuit to sense an intracardiac electrogram;

an auxiliary sensing circuit coupled the plurality of implantable subcutaneous electrodes, the auxiliary sensing circuit including a wireless electrocardiogram (ECG) sensing circuit to sense a subcutaneous ECG using the plurality of implantable subcutaneous electrodes;

a processing circuit having an input to receive a first signal selected from the intracardiac electrogram and the subcutaneous ECG;

a switch circuit coupled to the input of the processing circuit, the switch circuit configured to receive a selection signal and to connect the input of the processing circuit to the auxiliary sensing circuit such that the subcutaneous ECG is received by the processing circuit as a substitute signal for the intracardiac electrogram in response to the selection signal;

a selection circuit coupled to the switch circuit, the selection circuit configured to produce the selection signal in response to an indication of a failure mode in which the primary sensing circuit fails to provide reliable sensing of the intracardiac electrogram;

a hermetically sealed can housing the primary sensing circuit, the auxiliary sensing circuit, the processing circuit, the switch circuit, and the selection circuit; and

a header attached to the hermetically sealed can,

wherein the plurality of implantable subcutaneous electrodes are incorporated onto one or both of the hermetically sealed can and the header.

2. The system of claim 1, further comprising at least one lead connected to the primary sensing circuit, the at least one lead including one or more electrodes for sensing the intracardiac electrogram.

3. The system of claim 2, wherein the selection circuit comprises a lead failure detector, coupled to the at least one lead, to detect a lead failure substantially affecting a quality of the intracardiac electrogram, wherein the signal selection circuit produces the selection signal to connect the input of the processing circuit to the auxiliary sensing circuit when the lead failure is detected.

4. The system of claim 3, wherein the lead failure detector comprises a lead impedance measurement circuit.

5. The system of claim 1, wherein the selection circuit comprises a command receiver to receive an external command, wherein the selection circuit produces the selection signal based on the external command.

6. The system of claim 5, further comprising an external system communicatively coupled to the implantable medical device, the external system including a user input to receive the external command.

7. The system of claim 1, wherein the plurality of implantable subcutaneous electrodes comprises one or more header electrodes incorporated into the header.

8. The system of claim 7, wherein the plurality of implantable subcutaneous electrodes comprises a can electrode including at least a conductive portion of the hermetically sealed can.

9. The system of claim 1, wherein the implantable medical device comprises an antenna for telemetry, and wherein the plurality of implantable subcutaneous electrodes comprises an antenna electrode including a portion of the antenna.

10. The system of claim 1, wherein the plurality of implantable subcutaneous electrodes comprises one or more electrodes incorporated onto the hermetically sealed can.

11. The system of claim 10, wherein the plurality of implantable subcutaneous electrodes comprises two or more concentric electrodes incorporated onto the hermetically sealed can.

15. The system of claim 1, wherein the plurality of implantable subcutaneous electrodes are incorporated onto the implantable medical device.

16. The system of claim 15, wherein the implantable medical device comprises:

a hermetically sealed can housing the primary sensing circuit, the auxiliary sensing circuit, the processing circuit, the switch circuit, and the selection circuit; and

a header attached to the hermetically sealed can,

and wherein the plurality of implantable subcutaneous electrodes comprises one or more header electrodes incorporated into the header.

17. The system of claim 16, wherein the plurality of implantable subcutaneous electrodes comprises a can electrode including at least a conductive portion of the hermetically sealed can.

18. The system of claim 15, wherein the implantable medical device comprises an antenna for telemetry, and wherein the plurality of implantable subcutaneous electrodes comprise an antenna electrode including a portion of the antenna.

19. The system of claim 15, wherein the implantable medical device comprises a hermetically sealed can housing the primary sensing circuit, the auxiliary sensing circuit, the processing circuit, the switch circuit, and the selection circuit, and the plurality of implantable subcutaneous electrodes comprises one or more electrodes incorporated onto the hermetically sealed can.

12. A cardiac rhythm management (CRM) system, comprising:

an implantable medical device including;

a primary sensing circuit including an electrogram sensing circuit to sense an intracardiac electrogram;

an auxiliary sensing circuit including a wireless electrocardiogram (ECG) sensing circuit to sense a subcutaneous ECG;

a processing circuit having an input to receive a first signal being one of the intracardiac electrogram and the subcutaneous ECG;

a switch circuit coupled to the input of the processing circuit, the switch circuit configured to receive a selection signal and to connect the input of the processing circuit to one of the primary sensing circuit and the auxiliary sensing circuit according to the selection signal; and

a selection circuit coupled to the switch circuit, the selection circuit including a signal quality analyzer coupled to the primary sensing circuit, the signal quality analyzer adapted to produce a quality parameter indicative of a quality of the intracardiac electrogram, wherein the selection circuit is adapted to produce the selection signal to connect the input of the processing circuit to the auxiliary sensing circuit when the quality parameter is below a predetermined threshold; and

a plurality of implantable subcutaneous electrodes coupled to the auxiliary sensing circuit.

13. The system of claim 12, wherein the signal quality analyzer comprises a signal-to-noise ratio measurement circuit to measure a signal-to-noise ratio of the intracardiac electrogram.

14. The system of claim 12, wherein the plurality of implantable subcutaneous electrodes comprises at least one electrode incorporated onto the implantable medical device.